These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 39030964)
1. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Liu H; Xu L; Yue S; Su H; Chen X; Liu Q; Li H; Liang H; Chen X; He J; Ding Z; Zhang B Cancer Commun (Lond); 2024 Sep; 44(9):1018-1041. PubMed ID: 39030964 [TBL] [Abstract][Full Text] [Related]
2. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942 [TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modiļ¬cation of the lymphocyte antigen six family member E (LY6E) mRNA. Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284 [TBL] [Abstract][Full Text] [Related]
4. Loss of NAT10 Reduces the Translation of Xu T; Du T; Zhuang X; He X; Yan Y; Wu J; Zhou H; Li Y; Liao X; He J; Liu C; Dong Y; Ou J; Lin S; Chen D; Huang ZP J Am Heart Assoc; 2024 Oct; 13(20):e035714. PubMed ID: 39392166 [TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353 [TBL] [Abstract][Full Text] [Related]
6. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115 [TBL] [Abstract][Full Text] [Related]
7. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction. Wang XX; Zhao YM; Zhang QY; Zhao JX; Yin DH; Zhang ZZ; Jin XY; Li SN; Ji HY; Chen HY; Guo XF; Yu Y; Ma WY; Yan H; Li H; Ou-Yang QM; Pan ZW; Liang HH; Wang N; Chen W; Cai BZ; Liu Y Acta Pharmacol Sin; 2024 Jul; 45(7):1425-1437. PubMed ID: 38839936 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449 [TBL] [Abstract][Full Text] [Related]
9. NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis. Liu D; Kuang Y; Chen S; Li R; Su F; Zhang S; Qiu Q; Lin S; Shen C; Liu Y; Liang L; Wang J; Xu H; Xiao Y Ann Rheum Dis; 2024 Aug; 83(9):1118-1131. PubMed ID: 38724075 [TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Ding M; Yu Z; Lu T; Hu S; Zhou X; Wang X Clin Transl Med; 2024 Jul; 14(7):e1747. PubMed ID: 38961519 [TBL] [Abstract][Full Text] [Related]
12. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. Zhao CC; Sun X; Chen J; Geng BD Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918 [TBL] [Abstract][Full Text] [Related]
13. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA. Feng Z; Li K; Qin K; Liang J; Shi M; Ma Y; Zhao S; Liang H; Han D; Shen B; Peng C; Chen H; Jiang L J Hematol Oncol; 2022 Aug; 15(1):112. PubMed ID: 35978332 [TBL] [Abstract][Full Text] [Related]
14. Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10. Yang Y; Lu J; Liu Y; Zhang N; Luo Y; Ma M; Dong Z; Zhang S; Zheng MH; Ruan CC; Wan X; Hu C; Lu Y; Ma X; Zhou B Mol Metab; 2024 Nov; 89():102030. PubMed ID: 39293565 [TBL] [Abstract][Full Text] [Related]
15. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA. Li Z; Li D; Yang T; Yao C Cancer Biol Ther; 2023 Dec; 24(1):2274143. PubMed ID: 37948132 [TBL] [Abstract][Full Text] [Related]
16. Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway. Guo Q; Yu W; Tan J; Zhang J; Chen J; Rao S; Guo X; Cai K Cancer Med; 2024 Jun; 13(11):e7283. PubMed ID: 38826095 [TBL] [Abstract][Full Text] [Related]
17. The Cytidine N-Acetyltransferase NAT10 Participates in Peripheral Nerve Injury-Induced Neuropathic Pain by Stabilizing SYT9 Expression in Primary Sensory Neurons. Zhang M; Yang K; Wang QH; Xie L; Liu Q; Wei R; Tao Y; Zheng HL; Lin N; Xu H; Yang L; Wang H; Zhang T; Xue Z; Cao JL; Pan Z J Neurosci; 2023 Apr; 43(17):3009-3027. PubMed ID: 36898834 [TBL] [Abstract][Full Text] [Related]
18. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression. Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression. Xu N; Zhuo J; Chen Y; Su R; Chen H; Zhang Z; Lian Z; Lu D; Wei X; Zheng S; Xu X; Wang S; Wei Q Br J Cancer; 2024 Feb; 130(2):201-212. PubMed ID: 38040817 [TBL] [Abstract][Full Text] [Related]
20. NAT10 and cytidine acetylation in mRNA: intersecting paths in development and disease. Achour C; Oberdoerffer S Curr Opin Genet Dev; 2024 Aug; 87():102207. PubMed ID: 38820741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]